PET imaging of occult tumours by temporal integration of tumour-acidosis signals from pH-sensitive 64Cu-labelled polymers

scientific article published on 24 June 2019

PET imaging of occult tumours by temporal integration of tumour-acidosis signals from pH-sensitive 64Cu-labelled polymers is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/S41551-019-0416-1
P932PMC publication ID6928453
P698PubMed publication ID31235828

P50authorGuiyang HaoQ87996076
Jinming GaoQ88468318
Baran D SumerQ90426144
Chensu WangQ91808762
Gang HuangQ93000581
P2093author name stringXiankai Sun
Xiaofei Gao
Tian Zhao
Yihui Wang
Woo-Ping Ge
Yahong Xiong
Kien Nham
P2860cites workPET/CT in the thorax: pitfallsQ43714882
"USA-Fat": prevalence is related to ambient outdoor temperature-evaluation with 18F-FDG PET/CT.Q44539379
Brain tumour imaging with PET: a comparison between [ 18 F]fluorodopa and [ 11 C]methionineQ44632449
Integrated positron emission tomography/computed tomography in patients with non-small cell lung cancer: normal variants and pitfallsQ46384816
Cooperativity in macromolecular assemblyQ46725345
A practical way to improve contrast-to-noise ratio and quantitation for statistical-based iterative reconstruction in whole-body PET imaging.Q51802312
31P-MRS measurements of extracellular pH of tumors using 3-aminopropylphosphonate.Q55481907
Cooperativity Principles in Self-Assembled NanomedicineQ57358066
HER2 and choice of adjuvant chemotherapy for invasive breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-15Q73308218
HER-2/neu protein expression in breast cancer evaluated by immunohistochemistry. A study of interlaboratory agreementQ73423150
Atlas of confounding factors in head and neck PET/CT imagingQ83787270
A Transistor-like pH Nanoprobe for Tumour Detection and Image-guided SurgeryQ89116418
Multivalence cooperativity leading to "all-or-nothing" assembly: the case of nucleation-growth in supramolecular polymersQ90222581
Cancer genome landscapesQ22242276
Hallmarks of Cancer: The Next GenerationQ22252312
Understanding the Warburg effect: the metabolic requirements of cell proliferationQ24604760
Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR ImagingQ26796223
A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detectionQ28282608
Malignant gliomas in adultsQ29615708
pH-weighted molecular imaging of gliomas using amine chemical exchange saturation transfer MRIQ30976860
Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysisQ31950730
Beta-lapachone micellar nanotherapeutics for non-small cell lung cancer therapyQ33862927
Ultra-pH-sensitive nanoprobe library with broad pH tunability and fluorescence emissionsQ34045478
Comparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumorsQ34348544
Family of pH (low) insertion peptides for tumor targetingQ34636230
PET/CT artifactsQ34775884
Metabolic positron emission tomography imaging in cancer detection and therapy responseQ34786518
Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding propertiesQ35559623
Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging.Q35697657
pH imaging. A review of pH measurement methods and applications in cancers.Q35964389
pH in human tumour xenografts: effect of intravenous administration of glucoseQ35976576
Combined PET-CT in the head and neck: part 2. Diagnostic uses and pitfalls of oncologic imagingQ36190016
Metabolic Heterogeneity in Human Lung Tumors.Q36578111
"Green" atom transfer radical polymerization: from process design to preparation of well-defined environmentally friendly polymeric materialsQ36832479
A method to assess image quality for Low-dose PET: analysis of SNR, CNR, bias and image noiseQ37211967
A novel technology for the imaging of acidic prostate tumors by positron emission tomographyQ37213034
PET Imaging of Extracellular pH in Tumors with (64)Cu- and (18)F-Labeled pHLIP Peptides: A Structure-Activity Optimization StudyQ37278162
Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probesQ37465185
PET/CT in the assessment of previously treated skull base malignancies.Q37523571
A nanoparticle-based strategy for the imaging of a broad range of tumours by nonlinear amplification of microenvironment signalsQ37625279
False-positive uptake on 2-[¹⁸F]-fluoro-2-deoxy-D-glucose (FDG) positron-emission tomography/computed tomography (PET/CT) in oncological imagingQ37847699
Value of 11C-methionine PET in imaging brain tumours and metastasesQ38066701
Glioblastoma and other malignant gliomas: a clinical review.Q38160159
FDG-PET/CT pitfalls in oncological head and neck imaging.Q38243007
FDG-PET/CT in Infectious and Inflammatory DiseasesQ38519010
Prevalence and pattern of brown adipose tissue distribution of 18F-FDG in patients undergoing PET-CT in a subtropical climatic zoneQ39350304
Activation of P-glycoprotein (Pgp)-mediated drug efflux by extracellular acidosis: in vivo imaging with 68Ga-labelled PET tracerQ39696748
P433issue3
P304page(s)314-324
P577publication date2019-06-24
P1476titlePET imaging of occult tumours by temporal integration of tumour-acidosis signals from pH-sensitive 64Cu-labelled polymers
P478volume4

Reverse relations

cites work (P2860)
Q101409844Deep learning-enabled multi-organ segmentation in whole-body mouse scans
Q90481838Detection of Lymph Node Metastases by Ultra-pH-Sensitive Polymeric Nanoparticles
Q96431185Early stratification of radiotherapy response by activatable inflammation magnetic resonance imaging
Q96765485Exploiting metabolic acidosis in solid cancers using a tumor-agnostic pH-activatable nanoprobe for fluorescence-guided surgery
Q90282778Imaging of tumour acidosis with PET

Search more.